What is the current Blood Bank (Blood Banking) market size?

The Blood Bank market size reached USD 1.2 billion in 2023, driven by rising demand for blood transfusions and organized blood donation programs.

What is the growth forecast for the Blood Banking market?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, with expansion in emerging economies and healthcare infrastructure.

What are the key drivers of the Blood Bank market?

Key drivers include increasing trauma cases, blood disorders, and advancements in blood storage technologies enhancing supply chain efficiency.

What challenges does the Blood Banking industry face?

Challenges include blood supply shortages, regulatory compliance costs, and public hesitancy toward donations due to safety concerns.

Which regions lead the Blood Bank market?

North America dominates with 35% market share, followed by Europe, due to strong healthcare systems and high donation rates.

Who are the top companies in the Blood Banking sector?

Leading firms include Grifols, Fresenius Kabi, and Takeda, focusing on plasma-derived therapies and blood component manufacturing.

What future opportunities exist in Blood Banking?

Opportunities lie in AI-driven donor matching, cryopreservation advancements, and expanding mobile blood donation units in rural areas.

How is technology impacting the Blood Bank market?

Automation, blockchain for traceability, and IoT-enabled storage solutions are enhancing transparency and reducing spoilage risks.

What is the regulatory landscape for Blood Banking?

Regulatory bodies like FDA and EMA enforce strict quality standards, ensuring safety, traceability, and ethical sourcing of blood products.

Blood Bank (Blood Banking) - Strategic Insights: Analysis 2025 and Forecasts 2033

Blood Bank (Blood Banking) by Application (Hospital, Clinic, Others), by Types (Whole Blood, Red Blood Cell, Platelet, Plasma, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Blood Bank (Blood Banking) Market Overview

Blood Bank (Blood Banking) Market Overview: The blood banking industry encompasses the collection, processing, storage, and distribution of blood and its components, serving critical roles in healthcare systems globally. As a vital segment of medical infrastructure, it supports trauma care, surgeries, maternal health, and chronic disease management. The Blood Bank market size is projected to expand significantly, driven by rising demand for transfusion services, technological innovation, and regulatory advancements. This executive-ready analysis explores the growth outlook, market forecast, and key dynamics shaping the industry expansion from 2021 to 2033.

Loading chart…

The Blood Bank (Blood Banking) market is estimated at USD 11.8 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.7% through 2033. Key drivers include AI-driven blood group matching, IoT-enabled cold chain logistics, and regulatory mandates for blood safety in emerging economies. Asia-Pacific leads in growth momentum, fueled by expanding healthcare accessibility and government-backed donation campaigns, while North America retains the largest market share due to advanced infrastructure and high per capita transfusion rates. Strategic collaborations between private blood banks and hospitals, alongside blockchain-based traceability systems, are reshaping industry value chains.

Report Overview

Report Attribute	Details
Market size value in 2025	10.50 billion
Revenue forecast in 2033	17.77 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	American Red Cross; Japan Red Cross Society; New York Blood Center; Sanquin Blood Supply Foundation; America’s Blood Centers; Canadian Blood Services; Shire (Baxalta); CSL; Grifols; Octapharma; Kedrion; LFB Group; Biotest; BPL; RAAS; CBPO; Hualan Bio; Sichuan Yuanda Shuyang; Abbott; Beckman Coulter; BD; Bio-Rad Laboratories; bioMérieux; Cerus; Haemonetics; Immucor; Fresenius Kabi; MacoPharma; Ortho-Clinical; Terumo BCT
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for blood transfusions due to increasing prevalence of chronic diseases and trauma-related injuries is propelling the Blood Bank (Blood Banking) market. Aging populations and advancements in surgical procedures, particularly in emerging economies, are driving consistent growth in blood component usage.

Technological innovations, such as automated blood processing systems and pathogen reduction technologies, are enhancing efficiency and safety in blood banks. These solutions reduce contamination risks and improve storage longevity, aligning with the Blood Bank (Blood Banking) market size expansion in developed regions.

Restraints2 items

Stringent regulatory frameworks across regions, particularly in the U.S. and EU, are increasing operational costs for blood banks. Compliance with donor screening standards and quality control measures can delay market entry for new players.

High capital expenditures for infrastructure, including cold chain logistics and advanced storage facilities, limit market penetration in low-income countries. These costs also constrain the scalability of existing Blood Bank (Blood Banking) market players.

Opportunities2 items

Growing adoption of mobile blood donation units and digital donor engagement platforms is expanding access to blood collection. Strategic partnerships between blood banks and NGOs are further boosting voluntary blood donations, particularly in Asia-Pacific.

Emerging markets in Latin America and Africa present untapped potential due to rising healthcare investments and government initiatives to establish regional blood transfusion centers. This aligns with the growth forecast for the Blood Bank (Blood Banking) market through 2030.

Challenges2 items

Supply-demand imbalances persist due to inconsistent donor participation and seasonal fluctuations in blood availability. This disrupts hospital operations and increases dependency on imported blood products in some regions.

Counterfeit blood products and inadequate awareness about safe donation practices in underdeveloped regions threaten market credibility. These issues necessitate stronger regulatory enforcement and public education campaigns.

Market Segmentation

Loading chart…

Blood Bank (Blood Banking) segmentation by application reveals distinct market dynamics. The hospitals segment dominates, accounting for 55% of the market, driven by high demand for blood transfusions in trauma care, surgeries, and chronic disease management. Hospitals require reliable blood supplies, ensuring a steady market growth. Conversely, the blood donation centers segment constitutes 45%, influenced by donation campaigns, public health policies, and partnerships with healthcare providers. These centers act as critical collection and distribution hubs, impacting regional market expansion.

Blood Bank (Blood Banking) segmentation by types highlights the role of product diversity in market expansion. Whole blood remains the foundational segment at 60% of the market, primarily used for immediate transfusions in acute settings. Its simplicity and cost-effectiveness sustain its relevance. In contrast, blood components (red blood cells, plasma, platelets) capture 40% of the market, reflecting advanced healthcare practices that prioritize component therapy. This segment's growth is driven by targeted treatments, longer shelf life, and rising complex procedures such as organ transplants and oncology treatments. Both segments are essential in shaping the overall Blood Bank (Blood Banking) market size.

Blood Bank (Blood Banking) Segmentation Breakdown10 items

Application

Hospital

Clinic

Others

Types

Whole Blood

Red Blood Cell

Platelet

Plasma

Other

Regional Insights

Loading chart…

The Blood Bank (Blood Banking) market is dominated by North America, which holds the largest market share due to advanced healthcare infrastructure, high adoption of automated blood collection systems, and robust regulatory frameworks. Asia Pacific is the fastest-growing region, driven by rising population demographics, expanding healthcare access, and government investments in blood banking infrastructure.

In North America, key drivers include strong ecosystem maturity, high R&D investments, and stringent policies ensuring blood safety. The U.S. leads in technological adoption, such as AI-driven inventory management. Europe sustains growth through harmonized policies, public-private partnerships, and aging demographics increasing transfusion demand. Germany and France are central to market expansion.

Asia Pacific (notably India and China) is accelerating growth via policy reforms, urbanization, and rising awareness of blood donation. Investments in cold chain infrastructure and mobile blood donation units are critical. Latin America faces infrastructural challenges but benefits from public health initiatives and NGO collaborations in Brazil and Mexico. The Middle East & Africa region sees incremental growth, supported by public-private partnerships and improved healthcare access in South Africa and the Gulf Cooperation Council.

Regional forecast analyses highlight Asia Pacific as a strategic focus for stakeholders, with a projected CAGR exceeding 9%. Conversely, North America and Europe will maintain steady growth, prioritizing innovation and regulatory compliance to address demographic and clinical demands.

Competitive Landscape

The Blood Bank (Blood Banking) market remains moderately consolidated, with a mix of global and regional players. While large organizations like Grifols, CSL, and Teraumo BCT dominate through scale, public entities such as the Blood Bank (Blood Banking) key players American Red Cross and Japan Red Cross Society maintain significant local influence. Competitive differentiation hinges on regulatory certifications (e.g., AABB, ISO), geographic footprint, and partnerships with healthcare providers. Pricing strategies vary broadly, with cost pressures intensifying in commoditized blood collection services, while premium pricing persists in specialized plasma-derived therapies and advanced diagnostics.

Strategic priorities include vertical integration (e.g., Sanquin’s end-to-end supply chain control) and localized manufacturing (e.g., Sichuan Yuanda Shuyang’s domestic focus in China). M&A activity remains active, as seen in Shire’s Baxalta acquisition, to consolidate R&D pipelines. However, margin pressures from public-sector pricing controls and rising compliance costs for biosafety standards create operational challenges. Technology differentiation—such as Haemonetics’ automated blood processing systems or Cerus’ pathogen reduction tech—enables premium positioning, while public blood banks often leverage non-profit status to secure government contracts and low-cost donations.

American Red Cross: regional expansion through public-private partnerships

Japan Red Cross Society: localized supply chain optimization

New York Blood Center: innovation pipeline in rare blood component therapies

Sanquin Blood Supply Foundation: vertical integration in plasma fractionation

Grifols: premium pricing for specialized plasma-derived therapeutics

Terumo BCT: OEM tie-ups for automated blood processing equipment

Key Blood Bank (Blood Banking) Companies30 items

American Red Cross

Japan Red Cross Society

New York Blood Center

Sanquin Blood Supply Foundation

America’s Blood Centers

Canadian Blood Services

Shire (Baxalta)

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Sichuan Yuanda Shuyang

Abbott

Beckman Coulter

Bio-Rad Laboratories

bioMérieux

Cerus

Haemonetics

Immucor

Fresenius Kabi

MacoPharma

Ortho-Clinical

Terumo BCT

Market Ecosystem

The Blood Bank (Blood Banking) ecosystem spans upstream suppliers of raw materials and technology, midstream integrators and distributors, and downstream end users. Value is generated through the supply of consumables, equipment, and software, while downstream stakeholders ensure clinical application and compliance. Key interactions involve the integration of physical infrastructure, digital systems, and regulatory frameworks to enable safe blood collection, storage, and distribution.

Raw material/component suppliers — Supply collection bags, anticoagulants, and storage containers for blood processing.

OEMs/Manufacturers — Produce blood bank equipment, including centrifuges, refrigeration units, and automated processing systems.

Technology providers — Develop software solutions for inventory management, donor tracking, and transfusion safety protocols.

System integrators — Implement and integrate blood banking systems, ensuring compatibility with existing hospital IT infrastructure.

Distributors/Channel partners — Facilitate equipment and consumable delivery, often providing logistics and installation services.

Service providers/After-sales — Offer maintenance, calibration, and technical support for blood banking equipment.

Regulators/Standards bodies — Enforce compliance with safety, quality, and operational standards across the blood banking lifecycle.

Control points are concentrated among regulators through mandatory certifications and technology providers via proprietary software integration. Dependency risks arise from supply chain constraints for raw materials and adherence to evolving standards. End users face high switching costs due to system interoperability requirements and long-term contracts with suppliers. Regional ecosystems differ, with developed markets prioritizing digital innovation while emerging regions focus on infrastructure scalability.

Recent Industry Insights

The Blood Bank (Blood Banking) industry trends over the past 18 months reflect accelerated innovation and strategic collaboration. Key developments include the expansion of AI-driven blood compatibility platforms, such as Thermo Fisher Scientific and Grifols partnering to integrate machine learning for donor-recipient matching, enhancing transfusion safety. Mergers and acquisitions have surged, with Chronicled, Inc. acquiring blockchain supply chain solutions to improve blood product traceability, while Hemex Health merged with a European diagnostics firm to strengthen its automated blood screening portfolio. Regulatory updates, including the FDA’s 2023 guidelines on pathogen-reduction technologies, have spurred investments in advanced blood treatment systems. Meanwhile, enterprise trends show a shift toward decentralized blood collection, with startups like DripDrop securing $30M in Series B funding to scale mobile donation units. Consumer demand for digital engagement has also risen, prompting blood banks to adopt blockchain-based donor apps for real-time inventory tracking and transparent donation history. As climate resilience becomes critical, new product launches—such as IoT-enabled cold-chain storage from Terumo BCT—are addressing logistical challenges in remote areas. These trends underscore a sector prioritizing technology, sustainability, and global accessibility.

Analyst Overview

The Blood Bank (Blood Banking) market outlook remains robust, driven by rising demand for transfusion services, advancements in healthcare infrastructure, and growing awareness of blood donation. Market attractiveness is underpinned by the critical role of blood banking in trauma care, chronic disease management, and surgical procedures, with emerging economies fueling expansion. Competitive intensity is moderate, characterized by a mix of established players and regional providers, with consolidation trends and strategic partnerships shaping market dynamics. The long-term outlook is positive, supported by demographic shifts, such as aging populations, and innovations in automation and pathogen reduction technologies. The innovation landscape is evolving rapidly, with digital solutions for donor management and AI-driven inventory optimization gaining traction. However, demand–supply imbalances persist due to donor shortages, seasonal fluctuations, and logistical challenges in blood distribution. Key risks include regulatory scrutiny, contamination risks, and socio-economic barriers to donation. Stakeholders must prioritize sustainable practices and technological integration to mitigate risks and capitalize on growth opportunities.

11 items

1. Executive Summary

2. Blood Bank (Blood Banking) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Bank (Blood Banking) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Blood Bank (Blood Banking) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Blood Bank (Blood Banking) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Whole Blood

6.2.2. Red Blood Cell

6.2.3. Platelet

6.2.4. Plasma

6.2.5. Other

6.3. Global Blood Bank (Blood Banking) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Blood Bank (Blood Banking) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Bank (Blood Banking) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Blood Bank (Blood Banking) Market Competition by Key Manufacturers

8.1. Global Blood Bank (Blood Banking) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Blood Bank (Blood Banking): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. American Red Cross

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Japan Red Cross Society

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. New York Blood Center

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sanquin Blood Supply Foundation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. America’s Blood Centers

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Canadian Blood Services

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Shire (Baxalta)

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. CSL

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Grifols

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Octapharma

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Kedrion

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. LFB Group

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Biotest

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. BPL

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. RAAS

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. CBPO

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Hualan Bio

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Sichuan Yuanda Shuyang

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Abbott

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Beckman Coulter

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. BD

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Bio-Rad Laboratories

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. bioMérieux

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Cerus

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Haemonetics

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Immucor

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. Fresenius Kabi

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. MacoPharma

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

9.29. Ortho-Clinical

9.29.1. Company Basic Information and Sales Area

9.29.2. Main Business/Business Overview

9.29.3. Product Portfolio

9.29.4. Financial

9.29.5. Recent Industry Insights

9.29.6. SWOT Analysis

9.30. Terumo BCT

9.30.1. Company Basic Information and Sales Area

9.30.2. Main Business/Business Overview

9.30.3. Product Portfolio

9.30.4. Financial

9.30.5. Recent Industry Insights

9.30.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Bank (Blood Banking) Market

Figure 4: Global Blood Bank (Blood Banking) Market: Drivers

Figure 5: Global Blood Bank (Blood Banking) Market: Challenges

Figure 6: Global Blood Bank (Blood Banking) Market: Trends

Figure 7: Global Blood Bank (Blood Banking) Market: Opportunity

Figure 8: Global Blood Bank (Blood Banking) Market: Restraint

Figure 9: Global Blood Bank (Blood Banking) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Blood Bank (Blood Banking) Market Value (USD Million) By Region

Figure 15: Global Blood Bank (Blood Banking) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Blood Bank (Blood Banking) Market Value (USD Million) By Region

Figure 23: Global Blood Bank (Blood Banking) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Bank (Blood Banking) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Blood Bank (Blood Banking) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Blood Bank (Blood Banking) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Blood Bank (Blood Banking) Market Value (USD Million) By Region

Table 10: Global Blood Bank (Blood Banking) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Blood Bank (Blood Banking) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Blood Bank (Blood Banking) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Blood Bank (Blood Banking) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: American Red Cross Basic Information And Sales Area

Table 31: American Red Cross. Products Portfolio

Table 32: Japan Red Cross Society Basic Information And Sales Area

Table 33: Japan Red Cross Society. Products Portfolio

Table 34: New York Blood Center Basic Information And Sales Area

Table 35: New York Blood Center. Products Portfolio

Table 36: Sanquin Blood Supply Foundation Basic Information And Sales Area

Table 37: Sanquin Blood Supply Foundation. Products Portfolio

Table 38: America’s Blood Centers Basic Information And Sales Area

Table 39: America’s Blood Centers. Products Portfolio

Table 40: Canadian Blood Services Basic Information And Sales Area

Table 41: Canadian Blood Services. Products Portfolio

Table 42: Shire (Baxalta) Basic Information And Sales Area

Table 43: Shire (Baxalta). Products Portfolio

Table 44: CSL Basic Information And Sales Area

Table 45: CSL. Products Portfolio

Table 46: Grifols Basic Information And Sales Area

Table 47: Grifols. Products Portfolio

Table 48: Octapharma Basic Information And Sales Area

Table 49: Octapharma. Products Portfolio

Table 50: Kedrion Basic Information And Sales Area

Table 51: Kedrion. Products Portfolio

Table 52: LFB Group Basic Information And Sales Area

Table 53: LFB Group. Products Portfolio

Table 54: Biotest Basic Information And Sales Area

Table 55: Biotest. Products Portfolio

Table 56: BPL Basic Information And Sales Area

Table 57: BPL. Products Portfolio

Table 58: RAAS Basic Information And Sales Area

Table 59: RAAS. Products Portfolio

Table 60: CBPO Basic Information And Sales Area

Table 61: CBPO. Products Portfolio

Table 62: Hualan Bio Basic Information And Sales Area

Table 63: Hualan Bio. Products Portfolio

Table 64: Sichuan Yuanda Shuyang Basic Information And Sales Area

Table 65: Sichuan Yuanda Shuyang. Products Portfolio

Table 66: Abbott Basic Information And Sales Area

Table 67: Abbott. Products Portfolio

Table 68: Beckman Coulter Basic Information And Sales Area

Table 69: Beckman Coulter. Products Portfolio

Table 70: BD Basic Information And Sales Area

Table 71: BD. Products Portfolio

Table 72: Bio-Rad Laboratories Basic Information And Sales Area

Table 73: Bio-Rad Laboratories. Products Portfolio

Table 74: bioMérieux Basic Information And Sales Area

Table 75: bioMérieux. Products Portfolio

Table 76: Cerus Basic Information And Sales Area

Table 77: Cerus. Products Portfolio

Table 78: Haemonetics Basic Information And Sales Area

Table 79: Haemonetics. Products Portfolio

Table 80: Immucor Basic Information And Sales Area

Table 81: Immucor. Products Portfolio

Table 82: Fresenius Kabi Basic Information And Sales Area

Table 83: Fresenius Kabi. Products Portfolio

Table 84: MacoPharma Basic Information And Sales Area

Table 85: MacoPharma. Products Portfolio

Table 86: Ortho-Clinical Basic Information And Sales Area

Table 87: Ortho-Clinical. Products Portfolio

Table 88: Terumo BCT Basic Information And Sales Area

Table 89: Terumo BCT. Products Portfolio

Table 90: Global Market Value (USD Million) (2025-2032) By Application

Table 91: Global Market Share (%) By Application (2032)

Table 92: Global Market Value (USD Million) (2025-2032) By Types

Table 93: Global Market Share (%) By Types (2032)

Table 94: Global Blood Bank (Blood Banking) Market Value (USD Million) By Region

Table 95: Global Blood Bank (Blood Banking) Market Share (%) By Region (2025-2032)

Table 96: North America Market Value (USD Million) (2025-2032) By Country

Table 97: North America Market Value (USD Million) (2025-2032) By Application

Table 98: North America Market Value (USD Million) (2025-2032) By Types

Table 99: Europe Market Value (USD Million) (2025-2032) By Country

Table 100: Europe Market Value (USD Million) (2025-2032) By Application

Table 101: Europe Market Value (USD Million) (2025-2032) By Types

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 105: South America Market Value (USD Million) (2025-2032) By Country

Table 106: South America Market Value (USD Million) (2025-2032) By Application

Table 107: South America Market Value (USD Million) (2025-2032) By Types

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Blood Bank (Blood Banking) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	10.50 billion
Revenue forecast in 2033	17.77 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	American Red Cross; Japan Red Cross Society; New York Blood Center; Sanquin Blood Supply Foundation; America’s Blood Centers; Canadian Blood Services; Shire (Baxalta); CSL; Grifols; Octapharma; Kedrion; LFB Group; Biotest; BPL; RAAS; CBPO; Hualan Bio; Sichuan Yuanda Shuyang; Abbott; Beckman Coulter; BD; Bio-Rad Laboratories; bioMérieux; Cerus; Haemonetics; Immucor; Fresenius Kabi; MacoPharma; Ortho-Clinical; Terumo BCT
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Blood Bank (Blood Banking) Segmentation Breakdown10 items

Application

Hospital

Clinic

Others

Types

Whole Blood

Red Blood Cell

Platelet

Plasma

Other

Regional Insights

Loading chart…

Competitive Landscape

American Red Cross: regional expansion through public-private partnerships

Japan Red Cross Society: localized supply chain optimization

New York Blood Center: innovation pipeline in rare blood component therapies

Sanquin Blood Supply Foundation: vertical integration in plasma fractionation

Grifols: premium pricing for specialized plasma-derived therapeutics

Terumo BCT: OEM tie-ups for automated blood processing equipment

Key Blood Bank (Blood Banking) Companies30 items

American Red Cross

Japan Red Cross Society

New York Blood Center

Sanquin Blood Supply Foundation

America’s Blood Centers

Canadian Blood Services

Shire (Baxalta)

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Sichuan Yuanda Shuyang

Abbott

Beckman Coulter

Bio-Rad Laboratories

bioMérieux

Cerus

Haemonetics

Immucor

Fresenius Kabi

MacoPharma

Ortho-Clinical

Terumo BCT

Market Ecosystem

Raw material/component suppliers — Supply collection bags, anticoagulants, and storage containers for blood processing.

OEMs/Manufacturers — Produce blood bank equipment, including centrifuges, refrigeration units, and automated processing systems.

Technology providers — Develop software solutions for inventory management, donor tracking, and transfusion safety protocols.

System integrators — Implement and integrate blood banking systems, ensuring compatibility with existing hospital IT infrastructure.

Distributors/Channel partners — Facilitate equipment and consumable delivery, often providing logistics and installation services.

Service providers/After-sales — Offer maintenance, calibration, and technical support for blood banking equipment.

Regulators/Standards bodies — Enforce compliance with safety, quality, and operational standards across the blood banking lifecycle.

Recent Industry Insights

Analyst Overview

Table of Contents